V
Venkatramana D. Krishna
Researcher at University of Minnesota
Publications - 29
Citations - 824
Venkatramana D. Krishna is an academic researcher from University of Minnesota. The author has contributed to research in topics: Magnetic nanoparticles & Antibody. The author has an hindex of 11, co-authored 24 publications receiving 477 citations. Previous affiliations of Venkatramana D. Krishna include Indian Institute of Science.
Papers
More filters
Journal ArticleDOI
Giant magnetoresistance-based biosensor for detection of influenza A virus
TL;DR: This study showed that the GMR biosensor assay is relevant for diagnostic application since the virus concentration in nasal samples of influenza virus infected swine was reported to be in the range of 103 to 105 TCID50/mL.
Journal ArticleDOI
Nanotechnology: review of concepts and potential application of sensing platforms in food safety.
TL;DR: A brief overview of the recent emergence of nanotechnology-based techniques for the detection and monitoring of foodborne diseases is provided and the potential applications and future perspectives of nan technology on food safety are discussed.
Journal ArticleDOI
Portable GMR Handheld Platform for the Detection of Influenza A Virus
TL;DR: The Z-Lab point-of-care (POC) device is reported herein for sensitive and specific detection of swine influenza viruses with minimum sample handling and laboratory skill requirements and this platform allows lab-testing to be performed outdoors and opens up the applications of immunoassays in nonclinical settings.
Journal ArticleDOI
Magnetic Nanosensor-Based Virus and Pathogen Detection Strategies Before and During COVID-19
Kai Wu,Renata Saha,Diqing Su,Venkatramana D. Krishna,Jinming Liu,Maxim C.-J. Cheeran,Jian-Ping Wang +6 more
TL;DR: The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes CoV-19 (COVID-19), is a threat to the global healthcare system and economic security as discussed by the authors.
Journal ArticleDOI
Virus-Specific Cytolytic Antibodies to Nonstructural Protein 1 of Japanese Encephalitis Virus Effect Reduction of Virus Output from Infected Cells
TL;DR: The presence of nonstructural protein 1 (NS1)-specific antibodies in a significant proportion of convalescent-phase human serum samples obtained from a cohort in an area where Japanese encephalitis virus (JEV) is endemic provides a strong case for inclusion of the NS1 protein in next generation of JEV vaccines.